Back to Search Start Over

Influenza vaccination in the elderly

Authors :
Ruud Verhees
J A Knottnerus
Geert-Jan Dinant
Carel Thijs
Ton Ambergen
Family Medicine
Epidemiologie
RS: CAPHRI - R5 - Optimising Patient Care
FHML Methodologie & Statistiek
RS: CAPHRI - R1 - Ageing and Long-Term Care
Source :
PLoS ONE, PLoS ONE, Vol 14, Iss 5, p e0216983 (2019), PLOS ONE, 14(5):0216983. Public Library of Science
Publication Year :
2019
Publisher :
Public Library of Science, 2019.

Abstract

Influenza vaccination is proven effective in preventing influenza. However, long-term effects on mortality have never been supported by direct evidence. In this study we assessed the long-term outcome of influenza vaccination on mortality in the elderly by conducting a 25-year follow-up study of a RCT on the efficacy of influenza vaccination as baseline. The RCT had been conducted in the Netherlands 5 years before vaccination was recommended for those aged >65 and 17 years before recommending it for those aged >60. The RCT included 1838 community-dwelling elderly aged ≥ 60 that had received an intramuscular injection with the inactivated quadrivalent influenza vaccine (n = 927) or placebo (n = 911) during the 1991/1992 winter. In our follow-up study, outcomes included all-cause mortality, influenza-related mortality and seasonal mortality. Unadjusted and adjusted hazard ratios (HRs) were estimated by Cox regression and sub-hazard ratios (SHRs) by competing risk models. Secondary analyses included subgroup analyses by age and disease status. The vital status up to January 1, 2017 was provided in 1800/1838 (98%) of the cases. Single influenza vaccination did not reduce all-cause mortality when compared to placebo (adjusted HR 0.95, 95% CI 0.85−1.05). Also, no differences between vaccination and placebo group were shown for underlying causes of death or seasonal mortality. In those aged 60–64, median survival increased with 20.1 months (95% CI 2.4–37.9), although no effects on all-cause mortality (adjusted HR 0.86, 95% CI 0.72−1.03) could be demonstrated in survival analysis. In conclusion, this study did not demonstrate a statistically significant effect following single influenza vaccination on long-term mortality in community-dwelling elderly in general. We propose researchers designing future studies on influenza vaccination in the elderly to fit these studies for longer-term follow-up, and suggest age-group comparisons in observational research. Clinical trial registry number: NTR6179.

Details

Language :
English
ISSN :
19326203
Volume :
14
Issue :
5
Database :
OpenAIRE
Journal :
PLOS ONE
Accession number :
edsair.doi.dedup.....c94839bcd1134e7c345cc42c00e2930f
Full Text :
https://doi.org/10.1371/journal.pone.0216983